title: REMS; red tape, or a remedy for opioid abuse?
authors.affiliation: VP REMS Communications and Project Development, Aventine Co., Montclair, NJ, USA.
authors.forename: Stephen
authors.initials: S
authors.lastname: Porada
mesh_terms: D000701:Analgesics, Opioid / Q000009:adverse effects / Q000627:therapeutic use*; D059350:Chronic Pain / Q000188:drug therapy*; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence* / Q000379:methods; D033161:Government Regulation; D006300:Health Services Misuse / Q000331:legislation & jurisprudence; D006801:Humans; D009293:Opioid-Related Disorders / Q000517:prevention & control*; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data; D018570:Risk Assessment; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence*
chemical_list: D000701:Analgesics, Opioid